Grundinformationen
- Standard-SMILES
Cc1ccc(Cl)cc1N1CCNCC1- InChIKey
FVDJRHNUZNLRJC-UHFFFAOYSA-N- Summenformel
- C11H15ClN2
- Durchschnittliche Molmasse
- 210,7 g/mol
- Monoisotopische Masse
- 210,09237616
Namen und Bezeichner
- Bevorzugter Name
- N-(5-Chloro-2-methylphenyl)piperazine
- IUPAC
- 1-(5-chloro-2-methylphenyl)piperazine
- Lokaler Name
- N-(5-Chlor-2-methylphenyl)piperazin
- Englischer Name
- 1-(5-Chloro-2-methylphenyl)piperazine
- Summenformel
- C11H15ClN2
- Molmasse
- 210.7
Namen und Synonyme
1-(5-chloro-2-methylphenyl)piperazine76835-20-6Piperazine, 1-(5-chloro-2-methylphenyl)-N-(5-Chloro-2-methylphenyl)piperazineZTJ246H8JVEINECS 278-560-24-(2-methyl-5-chlorophenyl)piperazine1-(5-Chloro-o-tolyl)piperazineDTXSID80227652RefChem:828139DTXCID30150143278-560-2
Weitere Namen anzeigen
AKOS BBS-00003583TIMTEC-BB SBB003438LABOTEST-BB LTBB000768N-(5-CHLORO-2-METHYLPHENYL)-PIPERAZINE1-(5-Chloro-2-methylphenyl)-piperazine,98%1-(5-Chloro-2-methylphenyl)piperazine ,97.5%1-(5-Chloro-2-Methylphenyl)-piperazine, 98% 50GR
Piperazine,1-(5-chloro-2-methylphenyl)-MFCD00087128UNII-ZTJ246H8JVEN300-18966(5-chloro-2-methylphenyl)piperazine1-(5-chloro-2-methylphenyl)-piperazine1-(5-chloro-2-methyl-phenyl)piperazineOprea1_678325
Datenbank-Bezeichner
- CAS
76835-20-6- PubChem CID
- 693767
- DTXSID
DTXSID80227652- ChEMBL
CHEMBL5489631- UNII
- ZTJ246H8JV
- EC Number
- 278-560-2
- Nikkaji
- J267.444K
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,8
- Polarare Oberfläche (TPSA)
- 15,3 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 14
- Formalladung
- 0
- Komplexität
- 180
Physikochemische Eigenschaften
- Siedepunkt
- 342.56 °C · 342.56°C (rough estimate)
- Dichte
- 1.1197 · 1.1197 (rough estimate)
- Brechungsindex
- 1.573 · 1.573-1.576
- storage temp.
- Store at Room Tem.
- pka
- 8.85 · 8.85±0.10(Predicted)
- CAS Datenbank
- 76835 · 76835-20-6(CAS DataBase Reference)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P264, P264+P265, P270, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Sicherheitsdaten
- hs_code
- 29339900
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 37/39-26
Chemie und Industrie
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter24 Anbieter
T&W GROUP021-61551611 13296011611 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
上海安米克化学品有限公司微信 17321281695 18019252918 · [email protected]
韶关市启程生物科技有限公司18122215013 · [email protected]
赛默飞世尔科技(中国)有限公司800-810-5118 · [email protected]
北京伊诺凯科技有限公司400-810-7969 010-59572699 · [email protected]
上海遐瑞医药科技有限公司+86 21 61551611
PT CHEM GROUP LIMITED+86-85511178; +86-85511178 · [email protected]
北京六合宁远医药科技股份有限公司010-60400365-8001 15910885229 · [email protected]
九鼎化学(上海)科技有限公司4009209199 · [email protected]
Guangzhou Yuheng Pharmaceutical Technology Co., Ltd+8613580539051 · [email protected]
上海特伯化学科技有限公司021-58170097 · [email protected]
江苏艾康生物医药研发有限公司025-66113011 19370895928 · [email protected]
上海琼燕医药科技有限公司086-021-15821262312 15821262312 · [email protected]
厦门盈融达化工有限公司+86-0592-6210733 · [email protected]
聿锦(天津)科技有限公司13370351217 kungfu1217@1 · [email protected]
上海茉馥医药科技有限公司+86-188369842 +86-15618151133 · [email protected]
Hefei Hirisun Pharmatech Co., Ltd+8615056975894 · [email protected]
山西诺诚生物科技有限公司17835231871 · [email protected]
上海凯为化学科技有限公司021-58461859 15821823057 · [email protected]
重庆卡兰医药有限公司[email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
Hefei TNJ Chemical Industry Co.,Ltd.+86-0551-65418684 +86-18949823763 · [email protected]
Zugehörige Reaktionen
29
Verknüpfte Notizen
Wird geladen…